Compensation of fitness costs and reversibility of antibiotic resistance mutations.
about
Bacterial diversity and antibiotic resistance in water habitats: searching the links with the human microbiomeEvolution of Bacterial Pathogens Within the Human HostPre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitroGlobal analysis of the evolution and mechanism of echinocandin resistance in Candida glabrataGenome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug ResistanceSteering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic ResistanceEvolutionary dynamics of HIV at multiple spatial and temporal scales.Origin of robustness in generating drug-resistant malaria parasitesMounting resistance of uropathogens to antimicrobial agents: A retrospective study in patients with chronic bacterial prostatitis relapse.Antiviral drug resistance as an adaptive processGWAMAR: genome-wide assessment of mutations associated with drug resistance in bacteria.Limits to compensatory adaptation and the persistence of antibiotic resistance in pathogenic bacteria.Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune ResponseModeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient.Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?Compensating the Fitness Costs of Synonymous Mutations.Effect of antibiotics on bacterial populations: a multi-hierachical selection process.Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.Biomass composition: the "elephant in the room" of metabolic modellingResistance diagnosis and the changing epidemiology of antibiotic resistance.Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.Compensation of the metabolic costs of antibiotic resistance by physiological adaptation in Escherichia coli.The evolutionary epidemiology of multilocus drug resistance.Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa.Variable competitive effects of fungicide resistance in field experiments with a plant pathogenic fungus.Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.Fitness landscapes emerging from pharmacodynamic functions in the evolution of multidrug resistance.Amelioration of the Fitness Costs of Antibiotic Resistance Due To Reduced Outer Membrane Permeability by Upregulation of Alternative Porins.The experimental evolution of herbicide resistance in Chlamydomonas reinhardtii results in a positive correlation between fitness in the presence and absence of herbicides.Escaping an evolutionary lobster trap: drug resistance and compensatory mutation in a fluctuating environment.Reversing resistance: different routes and common themes across pathogens.The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa.Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound.The yield of experimental yeast populations declines during selection.ROLE OF SEX AND MIGRATION IN ADAPTATION TO SINK ENVIRONMENTSSend more data: a systematic review of mathematical models of antimicrobial resistanceEnvironmental pleiotropy and demographic history direct adaptation under antibiotic selectionManaging the emergence of pathogen resistance via spatially targeted antimicrobial use
P2860
Q27024003-CC2EEEAC-6BF4-4202-B993-0CC1F8E239D0Q28076624-D2686AC8-9964-4253-A78B-0A590447CD3AQ28478663-E6C80510-E3EE-401B-9964-A1FF3FC020CCQ28483785-82A65B06-1AA4-40ED-8DC2-3B42C4B2A2A3Q28545741-413024AB-BDEC-413E-9BA6-3A7476A51DC1Q28547894-E6A368D2-24EC-4FBB-8878-30AF81130853Q30416280-A04D1938-B030-40BB-B00B-CC9DBEAF6BA8Q30581496-13FBA5CB-C29F-4B47-9A5E-410E9F080A7CQ33863124-38DE8319-48DC-4AE5-AA56-4AC83C0AE602Q33878407-8EFA4259-ADE6-45D1-8ECF-C256F76B9437Q35005284-BA69DBFA-CF7D-49EE-8008-E44D233D2135Q35069590-747BC111-7DBD-4419-A945-28EF029EB33CQ35773895-72CC66A9-D509-4DEF-8E2A-9CA3ACA3DA3FQ36070976-F542A910-4D0B-4C14-8C74-BC54730F1FEAQ36154055-F7F08E3C-A6F1-4A0B-B88A-7268EA724933Q36275612-787FBFF0-3709-4E29-A9D7-550E6C752394Q36757725-7667E8CC-0F27-4D40-A09F-EB931DCD96A0Q36904243-81503572-6D1F-4E16-AC4D-59ED651924B7Q37595457-6A04DEA3-9094-4049-A063-8FC79E3C7C53Q38543385-9B249B94-BC0A-4241-BF59-433CED4EB788Q38695026-43EC7382-7BDC-4230-A8AB-2FDA4B3D245EQ39108975-6F5C8E3B-FABE-4965-B042-64E2EB798E20Q40499211-6E96B914-F56D-43AF-8C5E-B3658EABD46CQ41870270-F11B637B-A830-4DE6-8F98-981A212378DCQ45344370-BC7C0BCE-980D-464B-A4F0-B22F72FC5BEEQ45897898-2F781C85-1608-4DAD-89B8-70C9C1454BB5Q47424368-D3232AF7-A41A-4DDC-B3D2-2214AF5AE4DFQ47664492-F76FE72D-25B5-416C-96BD-070133741669Q51095192-39531C81-C73B-42DE-9F02-027FCA3BCE79Q51482800-0F2D2D40-96E6-4BA7-8B7E-1092CCC74DA8Q51552931-EC8D1E90-AD15-4631-BE27-E0BF4EC02C6BQ51600817-1B03CC20-2438-4EF9-9AC9-0A0D43E8B955Q53724442-BED520E2-8DAE-4678-958F-077420248D3CQ53743078-2F2C6321-F450-4864-8DE8-EEF847C8A930Q55024892-E0B23C78-1755-4C9B-996B-B1DDD4B2BBB1Q55554372-4561E963-5CC4-4C08-A934-FD90C6101A90Q57022724-85CF2737-E25B-4001-A1FA-DC64E7E823C0Q57064558-094FB6EA-E056-4E39-80BC-1E4204CE73ECQ58997135-7A967D37-228F-40F4-A8C7-2BB216FDA14BQ59136516-14B1F91E-2AA9-4B18-B3F6-3924104B19F4
P2860
Compensation of fitness costs and reversibility of antibiotic resistance mutations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Compensation of fitness costs and reversibility of antibiotic resistance mutations.
@en
Compensation of fitness costs and reversibility of antibiotic resistance mutations.
@nl
type
label
Compensation of fitness costs and reversibility of antibiotic resistance mutations.
@en
Compensation of fitness costs and reversibility of antibiotic resistance mutations.
@nl
prefLabel
Compensation of fitness costs and reversibility of antibiotic resistance mutations.
@en
Compensation of fitness costs and reversibility of antibiotic resistance mutations.
@nl
P2860
P356
P1476
Compensation of fitness costs and reversibility of antibiotic resistance mutations.
@en
P2093
Jan Engelstädter
Pia Schulz zur Wiesch
P2860
P304
P356
10.1128/AAC.01460-09
P407
P577
2010-02-22T00:00:00Z